COMPANY PROFILE · UPDATED 18 NOV 2025

Iovance Biotherapeutics

Iovance Biotherapeutics is a biopharmaceutical startup based in San Carlos, California. The company works to develop tumor-infiltrating lymphocyte (TIL) therapies against cancer.

iovance.com ↗

This profile is unclaimed — do you work here? Claim it

Claim it →

Founded: 2007
Headcount: 434
Open roles: 43
Last raised: Post Ipo Equity · Sign in to view

TECH STACK · FROM OPEN ROLES

How Iovance Biotherapeutics builds

From open roles — extracted from Iovance Biotherapeutics’s live job descriptions

Other Software & Platforms

Microsoft Office×11 Workday×10 Microsoft Project×2 Adobe Creative Suite NetSuite

Cloud Platforms

Google Cloud×2 Amazon S3 Amazon Web Services Microsoft Azure

DevOps & Infrastructure

Windows×2 Git

Databases

Elasticsearch OpenSearch SQL

Analytics & BI

Microsoft Excel Sigma

Programming Languages

Python

Collaboration & Productivity

Smartsheet

CRM & Sales Tools

Veeva

LEADERSHIP

Founders & key people

OPEN ROLES

Hiring at Iovance Biotherapeutics

View all 43 open roles →

FUNDING

Capital raised

Total Amount Raised: $1,576,400,128

Iovance Biotherapeutics Funding Rounds

Post Ipo Equity
$211M
Feb 20, 2024
Post Ipo Equity
$211M
Feb 19, 2024
Post Ipo Equity
$150M
Jul 10, 2023
Post Ipo Equity
$150M
Jul 9, 2023
Post Ipo Equity
$603.7M
May 27, 2020
Post Ipo Equity
$603.7M
May 26, 2020
Post Ipo Equity
$252.2M
Oct 11, 2018
Post Ipo Equity
$252.2M
Oct 10, 2018
Post Ipo Equity
$172.5M
Jan 24, 2018
Post Ipo Equity
$172.5M
Jan 23, 2018
Post Ipo Equity
$100M
Jun 3, 2016
Post Ipo Equity
$100M
Jun 2, 2016
Post Ipo Equity Investors
Quogue Capital
OrbiMed Advisors
Frazier Management
Broadfin Capital
Post Ipo Equity
$64M
Feb 26, 2015
Post Ipo Equity
$64M
Feb 25, 2015
Post Ipo Equity
$23M
Oct 31, 2013
Post Ipo Equity
$23M
Oct 30, 2013
IPO
Unknown
Aug 13, 2010
IPO
Unknown
Jan 1, 2010